Treating prostate cancer in the clinic while preserving quality of life.

An Unmet Need

Tens of thousands of men each year with prostate cancer seek treatments that impact their quality of life with significant risks of urinary or sexual dysfunction.

At Avenda Health, we believe patients should not have to choose between treating their prostate cancer and keeping their quality of life.

Our Technology

Our proprietary system uses a laser to precisely treat prostate tumors without compromising urinary or sexual function. Treatments are planned and confirmed in real-time using our proprietary sensor and machine learning algorithm. *This is an investigational device not currently available for clinical use.

How It Works

The Avenda Health platform delivers targeted treatment through focal laser ablation, minimizing the impact to healthy tissue. When compared to competing technologies, this ‘male lumpectomy’ is relatively inexpensive (no operating room), simple (local anesthesia), and quick (under an hour).

Plan

Intelligent Margin Prediction

Treat

Real-time Feedback and Control

Confirm

Precise Ablation

Our Team

Our world class team of biomedical innovators.

Shyam Natarajan, PhD

Founder / President
  • PhD in Biomedical Engineering from UCLA
  • Adjunct Assistant Professor of UCLA Urology, Surgery, and Biomedical Engineering
  • Background in image-guided diagnosis/therapy, embedded systems, and signal processing

Leonard S. Marks, MD

Founder / Chief Medical Officer
  • Professor and deKernion Endowed Chair of Urology at UCLA
  • Expert in Targeted Prostate Biopsy, Active Surveillance, and Focal Therapy

Brittany Berry-Pusey, PhD

Founder / VP of Business Development & Strategy
  • PhD in Biomedical Physics UCLA School of Medicine
  • UCLA Anderson School of Management and Stanford Graduate School of Business training
  • Background in Medical Device development, digital health, pharma

Recognition

1st Place in Los Angeles MedTech Innovator Competition, and selected for MedTech Innovator accelerator program (20 of 600 companies).

Publications

Contact Us